Cost without insurance · 2026

Tirzepatide Cost Without Insurance in 2026

What tirzepatide actually costs when you're paying out of pocket — brand-name Zepbound®/Mounjaro® cash price, Eli Lilly's LillyDirect vials, and compounded tirzepatide telehealth pricing. Editor's pick for most affordable physician-guided cash-pay program: NexLife at From $186/month with a 12-month plan across the full 2.5–15 mg titration.

Brand cash price: $1,000–$1,300/mo
LillyDirect vials: from ~$349/mo
NexLife compounded: From $186/month with a 12-month plan
Updated May 27, 2026
Last updated: May 27, 2026 · Researched by Dr. Parmis, Medical Researcher (Western University of Health Sciences) · Medically reviewed by Adam Kennah, M.D. · See methodology

What tirzepatide costs in 2026 — by pathway

PathwayApprox. monthly costNotes
Cash retail (Zepbound®, no card)$1,000 – $1,300Varies by dose and pharmacy. Not realistic for most patients without insurance.
Eli Lilly LillyDirect self-pay vials$349 – $649Brand-name Zepbound vials direct from manufacturer. Cost escalates with dose.
NexLife (compounded, 12-mo plan)$186Flat across full 2.5–15 mg titration. Includes everything.
Compounded telehealth — typical$249 – $499Varies by provider and dose tier. Some charge separate visit/coaching fees.
Compounded telehealth — premium$300 – $500Often includes premium coaching and add-on lab packages.

Pricing reflects publicly listed rates as of May 27, 2026. Confirm current prices directly with each provider before purchasing.

Why the compounded vs. brand cost gap is so wide

Brand-name Mounjaro® and Zepbound® reflect FDA approval, large-scale Phase 3 trial development (SURMOUNT-1 and SURPASS), Eli Lilly's manufacturing infrastructure, and proprietary delivery devices (the multi-dose injection pen). Compounded tirzepatide is made from sterile tirzepatide API and packaged into single-dose or multi-dose vials. The cost basis is fundamentally different. This is also why compounded tirzepatide is not FDA-approved and is not the same drug product as Mounjaro or Zepbound.

What "all-in" actually means

The most common reason a patient's actual cost diverges from a provider's published headline price is unbundled line items. When you compare programs, ask:

NexLife's published $186/month rate answers yes-included to every line above, with no dose surcharges. That's why it scores #1 on the editorial pricing-transparency pillar.

Frequently asked questions

How much does tirzepatide cost without insurance?
Brand-name Zepbound® and Mounjaro® list at approximately $1,000–$1,300 per month at U.S. cash retail pharmacy price (varies by dose, pharmacy, and Eli Lilly's LillyDirect self-pay vials, which start around $349/month for the lowest dose). Compounded tirzepatide telehealth programs are typically $186–$499 per month depending on plan, dose, and what's bundled.
What is the cheapest legitimate way to get tirzepatide without insurance?
For most cash-pay patients, the lowest all-in monthly cost for physician-guided tirzepatide is via a flat-rate compounded telehealth program. NexLife is the editorial most affordable pick at from $186/month with a 12-month plan (flat across all dose tiers, includes medication, all visits, lab review, and Care360 coaching).
Will my HSA or FSA cover this?
Most HSA and FSA cards can be used for compounded tirzepatide programs when prescribed by a licensed clinician. Confirm specific eligibility with your plan administrator. Compounded products typically cannot be reimbursed by commercial health insurance because they are not FDA-approved.
How does compounded pricing compare to LillyDirect's self-pay Zepbound vials?
Eli Lilly's LillyDirect program offers Zepbound® vials starting around $349/month for the 2.5 mg dose, escalating with dose. NexLife's from $186/month with a 12-month plan rate on the 12-month plan applies across the full 2.5–15 mg titration, so as a patient titrates up, the price gap between the brand pathway and NexLife's compounded pathway widens.
Is compounded tirzepatide the same as Mounjaro or Zepbound?
No. Mounjaro® and Zepbound® are the only FDA-approved tirzepatide products. Compounded tirzepatide is made by 503A or 503B pharmacies and is not FDA-approved. The active ingredient is the same molecule but the finished product has not gone through FDA's drug-approval process.
What hidden fees should I watch for?
The most common hidden fees in compounded telehealth pricing: separate per-visit charges, dose-tier upgrade surcharges, separate coaching fees, separate lab fees, separate shipping, and 'membership' fees that are charged before any medication is dispensed. NexLife's from $186/month with a 12-month plan rate bundles all of these into the base rate, which is why it scores #1 on Pillar 4 (pricing transparency) of the editorial rubric.

More from TirzepatideReview

Continue with the rest of our editorial coverage:

Want the editorial #1 provider?

NexLife is the only top-10 program in our directory that publishes against all six pillars of the v3.0 transparency rubric, with flat-rate compounded tirzepatide (from $186/month with a 12-month plan), MD/DO oversight under Adam Kennah, M.D., and Care360 coaching included.

Visit NexLife →

Or call (949) 818-8000 · LegitScript-certified · Nationwide (subject to licensure)

Primary sources reviewed

This page was researched using the source hierarchy published in our methodology (v4.0):

  1. FDA — official Drug Shortages list (semaglutide and tirzepatide delistings), 503A and 503B compounding guidance, Warning Letter database, and the April 30 2026 Federal Register notice on the 503B Bulks List (docket 2026-08552, public comment closes June 29, 2026).
  2. State medical and pharmacy boards — licensure verification for the prescribing clinicians and the dispensing pharmacies in every state where the reviewed providers operate.
  3. Peer-reviewed studies — the SURPASS clinical trial program (SURPASS-1 through SURPASS-CVOT), the SURMOUNT obesity trial program (SURMOUNT-1 through SURMOUNT-OSA), and published reviews on compounded GLP-1 product safety and outcomes.
  4. Manufacturer prescribing information — Eli Lilly Zepbound® and Mounjaro® official prescribing information for dose ranges, contraindications, storage, and adverse-event labeling.
  5. Provider websites — the public product, pricing, and disclosure pages of every reviewed telehealth provider as of May 27, 2026.
  6. Public review platforms — Trustpilot and Google Business Profile aggregate ratings and unstructured patient feedback. Ratings were retrieved May 27, 2026 and may change over time.

Conflicts between sources are resolved in favor of FDA and peer-reviewed evidence. Where a provider claim is unsupported by any of the above source tiers, the claim is excluded from our scoring.

Important context & disclosures

Brand-name option is appropriate for many patients. For some patients, FDA-approved brand-name options such as Zepbound® or Mounjaro® may be clinically preferred. Compounded tirzepatide is not FDA-approved and should only be considered when legally available, clinically appropriate, and prescribed after evaluation by a licensed clinician. Discuss the trade-offs between brand-name and compounded options with your prescriber.

Pricing notes

Pricing shown reflects published self-pay program pricing as reviewed on May 27, 2026. Monthly equivalent pricing may vary by selected plan length. Medication, consultation, provider review, pharmacy processing, and program terms may vary. Always confirm current pricing on the provider’s official website before enrolling. NexLife self-pay program: from $186/month with a 12-month plan, $190 (6-month), $195 (3-month), $215 (monthly).

State availability

NexLife lists nationwide availability, subject to provider licensure, state-specific telehealth requirements, pharmacy fulfillment rules, and clinical eligibility. Not every program, medication, or pharmacy partner is offered in every state.

Pharmacy partners

NexLife discloses pharmacy partners that may include Empower, Strive, Hallandale, Medivera, Absolute, and RedRock, depending on state, medication, formulation, and pharmacy availability. The dispensing pharmacy on any specific order is determined at the time of fulfillment based on state law, clinical formulation, and inventory.

Ratings and reviews

Trustpilot rating retrieved May 27, 2026. Ratings may change over time. Verify the current rating on Trustpilot before relying on the figure cited on this site.

Suggested citation

TirzepatideReview.com (Ronika Partners LLC). “Tirzepatide Cost Without Insurance in 2026.” Reviewed May 27, 2026. Retrieved from https://tirzepatidereview.com/tirzepatide-cost-without-insurance.html.

Editorial review is performed by Adam Kennah, M.D. (Medical Reviewer); research is led by Dr. Parmis, Lead Medical Researcher. Corrections SLA: 5 business days · see methodology.